Backers put $12.7M behind Enterin's Parkinson's disease approach - FierceBiotech
https://www.neurotalk.org//t2.gstati...0RVNIxwqSYHZbS
FierceBiotech <img alt="" height="1" width="1"> Backers put $12.7M behind Enterin's Parkinson's disease approach FierceBiotech Philadelphia biotech Enterin has raised $12.7 million in funding to pursue its hypothesis that the origins of Parkinson's disease start in the gut, not the brain. The first-round financing is backed by new investor New Ventures III and will help ... Enterin Completes $12.7M Series A FinancingFinSMEs (blog) all 2 news articles » More... |
All times are GMT -5. The time now is 07:57 PM. |
Powered by vBulletin Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.
vBulletin Optimisation provided by
vB Optimise v2.7.1 (Lite) -
vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.